NFKB1 and diabetic kidney disease: In diabetic nephropathy models, Nrf2 activation can simultaneously inhibit ROS generation and the NF-κB inflammatory pathway (Lv et al., 2023), while ERS inhibition can block the CHOP-mediated mitochondrial apoptosis pathway (Zhang et al., 2016).